Zhixiang Jintai (688443.SH): GR2303 injection obtains the approval notice for drug clinical trials.

Wisdom Finance APP News, Zhixiang Jintai (688443.SH) announced that recently, the company has received the "Notice of Drug Clinical Trial Approval" issued by the National Medical Products Administration. The company's clinical trial application for the investigational product GR2303 injection has been approved, allowing the product to conduct clinical trials for the indication of inflammatory bowel disease.